INVEST IN TRUBRAIN TODAY!

Wearable Tech for Anxiety

TruBrain is launching wearable technology for anxiety, using established technology that has been cleared by the FDA. Anxiety Market size of $11 Billion. Designed by PhD neuroscientists and notable European industrial designers. Profitable brand with $19 million in lifetime sales. Featured in Forbes, CNBC & Bloomberg.

This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
TruBrain

$1,205,288.52 Raised

Offering Circular | Selected Risks Related to this Offering | TruBrain's SEC EDGAR Page


For more information on TriplePulse, Inc. (TruBrain), download and review the Offering Circular. The Offering Circular should be reviewed before making an investment decision.

.......

.......


Overview


Tackle Anxiety with TruBrain


Wearable tech can help improve how you exercise, sleep, and now.. how you think. Introducing the TruBrain wearable. The power to fight anxiety, without serious side effects - all with the click of a button.


Treat anxiety in a better, non-pharmaceutical way thanks to TruBrain. While most anxiety treatments involve Rx pills that carry side effects, our neuroscience team has built a smart wearable that conquers anxiety at the source, your brain. Built in collaboration with Tri̇di̇ Teknoloji̇ and a notable European industrial design team.



Taking the leading brand in cognitive healthcare to new heights. Join the team with $19M in sales and common investors in AirBnB and Uber. 


WATCH Joe Rogan discuss Anxiety & the Brain with Dr. Andrew Hill



The Problem


Anxiety is the enemy of cognitive health 


.......


.....

......

.......

..........

..........


The market


Demand for anxiety treatments is growing


Anxiety is crippling to the cognitive health of nearly 125M Americans. And that number is growing. The World Health Organization estimates that since 2020, the amount of people suffering with anxiety has increased 25% worldwide. 


Large hardware technology firms often avoid the medical device category due to the compliance and scientific expertise required, leaving an opportunity for more nimble, specialized brands like TruBrain to build market share.


the solution


Wearable Tech for Anxiety




.......

.......

.......



Our team has spent considerable time validating our path to market. We believe that it is optimal for us to start as a Class II medical device for anxiety, versus Class III for depression. This allows us to save considerable time, money, and risk of Cranial Electrotherapy Stimulators achieving FDA Class III status.

Traction


.......

.......

.......

Customers 🖤 TruBrain

TruBrain customers come from all walks of life and work in nearly every profession. Members of the armed forces order TruBrain to more than 70 bases around the globe. Parents take TruBrain after a long day of work so they’ll still have energy to read to their kids and help them with their homework. Writers, producers, and artists swear by TruBrain to boost their creative process. Our customers live in over 80 countries around the world. We work to offer compelling, proactive, healthy alternatives to low-performance packaged foods and over-stimulating pharmaceuticals.



*These testimonials may not be representative of the experience of other customers and are not a guarantee of future performance or success


In the Press

*These testimonials may not be representative of the experience of other customers and are not a guarantee of future performance or success

We read minds. Literally.

At TruBrain, our focus is human performance, and our products are designed to enhance your brain's natural abilities. We bring high-performance food and beverage nutrition that delivers positive, measurable outcomes to mainstream consumers.  Brainwave measurement is at the core of our origin as a company. We never claimed to be the smartest people on the planet, but we know some of the people who are – artists, surgeons, CEOs, and musicians. So we picked their brains, literally. We studied their thought patterns, their ability to handle stress, how they thought on their feet, and how they dealt with distractions. This led to the understanding of optimal brainwave patterns and the beginning of our journey to help people find their true brain.


OUR TEAM


Consumer execs & neuroscience nerds

We’re led by a visionary founder and veteran leadership with wide experience in neuroscience, healthcare, & consumer experience. Our CEO, Chris Thompson, has deep industry experience in consumer packaged goods - he managed billion dollar brands for Unilever, one of the largest CPG companies in the world. We use what we sell. Whether it is Chris testing Ketones during endurance training or Dr. Andrew Hill testing the latest neurotechnology in the EEG brain lab - we take it, we test it, we share it, we improve it. We have fostered a team whose collective efforts are all driven toward elevating the lives of our customers. Our purpose is to empower people to do their best thinking.


Our Investors

WHY INVEST


Expand with us

Our customers asked us to work on a large barrier in their way of performance - anxiety. We are so excited to attack the anxiety market with our wearable technology by top neuroscientists. We believe this will offer a compelling alternative to pharmaceuticals that have many side effects and will further our reach and status as the leading brand in cognitive healthcare.


Our mission is to make high function solutions accessible to mainstream consumers. Our products deliver a material benefit in people’s lives, and our role is to help them access these benefits. We believe the direct relationship with consumers is the most valuable component in the cognitive healthcare system, and we work to offer compelling, proactive health alternatives to low-function packaged goods and overly stimulating pharmaceuticals. 


The expansion of our product portfolio to include wearables, and the ability to offer a personalized healthcare experience only furthers our standing as one of the leading brands in the space. We think that through our brand equity, technology, extensive press coverage, and market timing, we will scale to widespread acceptance.


Join us and say hello to your TruBrain.


Chris Thompson, CEO



Footnotes

[1] - https://www.globenewswire.com/news-release/2019/01/11/1690384/0/en/Global-Nootropics-Market-Will-Reach-USD-5-959-Million-By-2024-Zion-Market-Research.html

[2] - https://www.prnewswire.com/news-releases/the-global-ketogenic-diet-food-market-is-forecasted-to-reach-usd-12-35-billion-in-2024--at-an-estimated-cagr-of-5-3-300879801.html

[3] - https://bit.ly/36efVUe

[4] - https://www.nytimes.com/2004/10/12/business/company-news-abbott-to-acquire-eas-for-320-million.html

[5] - https://www.forbes.com/sites/elanagross/2020/08/31/bayer-agrees-to-buy-personalized-vitamin-company-careof-at-225-million-valuation/?sh=56d6b0c4398d

[6] - https://www.prnewswire.com/news-releases/kellogg-adds-rxbar-fastest-growing-us-nutrition-bar-brand-to-wholesome-snacks-portfolio-300532438.html

[7] - https://www.bloomberg.com/news/articles/2020-10-01/hims-inks-1-6-billion-deal-to-go-public-via-oaktree-spac

[8] - https://www.cnbc.com/2019/05/10/why-amazon-bought-pillpack-for-753-million-and-what-happens-next.html

[9] - https://www.foodbusinessnews.net/articles/11026-hershey-to-acquire-amplify-snack-brands-for-1-6-billion

[10] - https://pubmed.ncbi.nlm.nih.gov/30597564/

[11] - https://www.businessnewsdaily.com/5658-easy-productivity-tips.html#the-negative-impact-of-multitasking

[12] - https://www.sciencedaily.com/releases/2018/07/180710104631.htm


---


AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT.


THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT CAN BE FOUND HERE.


THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.


WHILE THE COMPANY HAS SIGNED A QUOTATION AGREEMENT TO TRADE THE SECURITIES OFFERED ON STARTENGINE SECONDARY’S NEW ALTERNATIVE TRADING SYSTEM (THE “ATS”), A COMPANY WHICH INTENDS TO BE QUOTED ON THE MARKETPLACE WILL BE SUBJECT TO CERTAIN REQUIREMENTS WHICH THE COMPANY MAY OR MAY NOT BE ABLE TO SATISFY IN A TIMELY MANNER. EVEN IF A COMPANY IS QUALIFIED TO QUOTE ITS SECURITIES ON THE MARKET, THERE IS NO GUARANTEE AN ACTIVE TRADING MARKET FOR THE SECURITIES WILL EVER DEVELOP, OR IF DEVELOPED, BE MAINTAINED.  YOU SHOULD ASSUME THAT YOU MAY NOT BE ABLE TO LIQUIDATE YOUR INVESTMENT FOR SOME TIME OR BE ABLE TO PLEDGE THESE SHARES AS COLLATERAL.


TruBrain 17b Disclosure

Browse
Drop image
(or click)

Loading image

ABOUT

HEADQUARTERS
3103 Neilson Way, Suite D
Santa Monica, CA 90405

TruBrain is launching wearable technology for anxiety, using established technology that has been cleared by the FDA. Anxiety Market size of $11 Billion. Designed by PhD neuroscientists and notable European industrial designers. Profitable brand with $19 million in lifetime sales. Featured in Forbes, CNBC & Bloomberg.

TERMS

TruBrain
Overview
PRICE PER SHARE
$0.43
DEADLINE
Jun 11, 2023
VALUATION
$24.34M
AMOUNT RAISED
$1,205,288.52
Breakdown
MIN INVESTMENT
$473
MAX INVESTMENT
$1,999,999.95
MIN NUMBER OF SHARES OFFERED
23,255
OFFERING TYPE
Equity
ASSET TYPE
COMMON
SHARES OFFERED
Common Stock
MAX NUMBER OF SHARES OFFERED
21,662,790

Maximum Number of Shares Offered subject to adjustment for bonus shares


Company

:

TriplePulse, Inc.

Corporate Address

:

3103 Neilson Way, Suite D, Santa Monica, CA 90405

Offering Minimum

:

$9,999.65

Offering Maximum

:

$9,315,000.00

Minimum Investment Amount

(per investor)

:

$473.00











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

23,255

Maximum Number of Shares Offered

:

21,662,791

Price per Share

:

$0.43

Pre-Money Valuation

:

$24,337,270.00











x

ALL UPDATES

03.17.23

We just hit $1.2 Million raised!

We are very excited to announce that we’ve surpassed $1.2M in funding from our current StartEngine round

Our team of neuroscientists at TruBrain is working to solve the anxiety problem that impacts nearly 125 million Americans each year. This is an $11 Billion market!

By combining cognitive healthcare with wearable technology, TruBrain is set to become a leader in the industry.

Become an investor today to stay one step ahead.


This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

03.16.23

500 Startups invested in TruBrain and...

500 Startups is one of the 4 Venture Capital Firms that have invested in TruBrain. This venture capital firm has found success investing in several of its portfolio companies like:

  • Reddit: valued at $6.6 Billion
  • FabFitFun: valued at $1 Billion
  • Canva: valued at $40 Billion
  • CreditKarma: acquired for $8.1 Billion
  • BarkBox: IPO'd at $1.6 Billion
  • Figs: IPO'd at $3 Billion

See why the 500 Startups VC Firm invested in TruBrain


This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

03.09.23

WSJ reviews problems with Rx for Anxiety

In a recent WallStreet Journal article, America’s fascination with prescription drugs to treat anxiety was explored. “Fifty-seven percent of Gen Z are consistently taking prescription medications, largely to deal with increased rates of both depression and anxiety.” The article speaks to the irresponsibility of pushing prescriptions, and leaves the reader looking for doctors to look at alternatives.

TruBrain’s wearable device can be one of those alternatives to treat anxiety, without the nasty side effects of pharmaceuticals.

 

Compare TruBrain's Wearable Technology to Traditional Pharmaceuticals


This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

03.07.23

TruBrain’s new tool to fight Anxiety

Over 125 million Americans suffer with Anxiety each year. TruBrain is setting out to change that with a non-pharmaceutical solution. Designed by TruBrain’s Neuroscience team, our new wearable device utilizes technology cleared by the FDA to provide a solution for anxiety without the typical side-effects of pharmaceuticals.                                                        


Learn more about how TruBrain's device fights anxiety


This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

03.04.23

TruBrain adds another 1,000+ investors

TruBrain has added another 1,000+ new investors. These investors have joined 4 VC Firms, like 500 Startups, that have invested in successful companies like Uber, Reddit, and AirBnB. It is exciting to see the continued support for TruBrain’s campaign to develop wearable devices for anxiety and further their presence as a leader in cognitive healthcare.


See why 1,000 more investors have joined TruBrain's campaign


This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

02.21.23

WATCH: Joe Rogan on TruBrain’s Wearable Tech

                                                                        

TruBrain’s Dr. Andrew Hill was a guest on the Joe Rogan Experience. While there, they discussed the role that anxiety plays in cognitive health, and the impact that wearable tech can have. Take a look at the highlights of that discussion here.

                       

See TruBrain's Dr. Andrew Hill discuss Anxiety and Wearable Tech with Joe Rogan

                       

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

02.16.23

TruBrain featured in Yahoo Finance!

                                                                        

TruBrain’s Wearable Technology was recently covered in a story by Yahoo Finance! The article discussed the problem of stress and anxiety that impacts millions of Americans each year. That’s where TruBrain’s non-pharmaceutical solutions come in. TruBrain’s new Wearable Tech is designed to fight anxiety with FDA Cleared technology.

                       

Learn more about the tech featured in Yahoo Finance!

                  
     

Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17b disclosure linked in the campaign page for more information.

                       

TruBrain's Reg A+ offering is made available through StartEngine Primary, LLC, member FINRA /SIPC.This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view TruBrain's offering circular and risks associated with this offering.

02.13.23

TruBrain has raised over $1.1 Million!

                                                                        

TruBrain has crossed over $1.1 Million raised. With the backing of 4 VC funds and 2,000+ StartEngine investors, TruBrain has a strong investor community. Our advances into Wearable technology for Anxiety are primed to disrupt the pharmaceutical industry. So join this profitable, venture backed company today!

                       

Remember, every investor gets $325 worth of free product along with their shares!

                       

Join over 4 VC funds and over 2,000+ investors

                       


This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

02.09.23

👀 Check Out TruBrain’s Updated Campaign Page!

TruBrain is developing Wearable Tech to Combat Anxiety. We’ve completely overhauled our campaign page to share more information about the devices we have coming. Check out these exciting new updates on TruBrain’s Wearable Technology!                   
    

And remember, all investors above $1,450 get a free Wearable device.

                       

View the updated Campaign Page.


                       

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

01.27.23

TruBrain crosses $19M sold!

                                                                        

TruBrain continues to grow year-over-year and build on our status as a leader in the cognitive healthcare space. We have crossed $19 Million in lifetime revenue and are well on our way to $20 Million and beyond. We look forward to continuing to expand our product portfolio in 2023 with the launch of several new products. We’re also excited to launch our new Smart wearable device. Now is the time to join our investor community as we approach these upcoming milestones. Join us today!

                       

Invest in this growing healthcare company


                       

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

Owners bonus
Stack Owner's Bonus & Rewards!

Members get an extra 10% shares in addition to rewards below!

REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign perk. Get rewarded for investing more into TruBrain.

$473

StartEngine Owner’s Bonus

This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

$473

Tier 1

Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, and 1 TruBrain merchandise).

$1,450

Tier 2

Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device).

$2,950

Tier 3

30% Lifetime discount on our products. +  Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device).

$4,950

Tier 4

40% Lifetime discount on our products.*, 5% Bonus Shares, Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device).

$9,950

Tier 5

50% Lifetime discount on our products., 10% Bonus Shares, Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device)., Beta test group.

$24,950

Tier 6

50% Lifetime discount on our products, 15% Bonus Shares, Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device), Annual conference call with TruBrain’s CEO Meeting.

JOIN THE DISCUSSION













0/2500

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

WHY STARTENGINE?

REWARDS

We want you to succeed and get the most out of your money by offering rewards and memberships!

SECURE

Your info is your info. We take pride in keeping it that way!

DIVERSE INVESTMENTS

Invest in over 200 start-ups and collectibles!

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

PREVIOUSLY CROWDFUNDED
$2,321,893.88
RAISED
$1,205,288.52
INVESTORS
1,017
MIN INVEST
$473
VALUATION
$24.34M

@ 2022 All Rights Reserved

Apple Store Logo

Get To Know Us

Our Team

Careers

Blog

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.


www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.


Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.


Investment opportunities posted and accessible through the site are of three types:


1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.


Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.


By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.


Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.


California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.


StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.